Statement by the Group Chief Executive
Having taken on the role of Group Chief Executive, from January 2025, I have received a comprehensive handover from my executive team at ASPH and Katie Fisher, who undertook the role of Interim Chief Executive from May 2024.
Financially, we ended the year with a deficit of £19.3m, with our turnover increasing by 10.9% to £492.5m from £444.2m in 2023/24. We continued to invest in much needed capital schemes, including the opening of the Surrey Surgical Centre at Ashford Hospital and the development of the Woking Community Diagnostic Centre which has recently opened, as well as the building of a new Macmillan Cancer Support Centre in Ashford Hospital. All of which will provide improved services and facilities for our teams and patients.
Read more in our latest Annual Accounts and Report and Quality Account.
Louise Stead
Group Chief Executive
Performance Reports Presented to Trust Board
More information on performance is given in our board papers.
